Daptomycin Does Not Exert Immunomodulatory Effects in an Experimental Endotoxin Model of Human Whole Blood
Authors:
- Markus RothenburgerMRMarkus Rothenburger
- Claudia MarsikCMClaudia Marsik
- Sonja WuenscherSWSonja Wuenscher
- Martin PopovicMPMartin Popovic
- Georg EndlerGEGeorg Endler
- Oswald WagnerOWOswald Wagner
- Christian JoukhadarCJChristian Joukhadar
- 11 September 2007
- journal article
- Published by S. Karger AG in Pharmacology
- Vol. 81 (1) , 57-62
Abstract
Background: Recent studies have shown that distinct classes of antimicrobial agents might exert immunomodulatory effects in experimental settings. Daptomycin is the first member of the class of cyclic lipopeptide antibiotics, which exert their antimicrobial activity via a unique mode of action on the bacterial cytoplasmic membrane. Thus, we tested its ability to influence pro-inflammatory cytokines by use of an established experimental model of human endotoxemia. Methods: A controlled experimental study design with 4 parallel groups was used. Whole blood from 10 healthy male volunteers was incubated either with saline (negative control), daptomycin (40 µg/ml, control), lipopolysaccharide (LPS; 50 pg/ml, positive control), or the combination of daptomycin plus LPS for 4 h. Real-time polymerase chain reaction was utilized for the measurement of selected pro-inflammatory cytokines, namely IL-1β, IL-6 (high sensitivity) and TNF-α on the mRNA level. Protein concentrations of these respective cytokines were measured in the supernatant using a commercially available ELISA. Results: Incubation of whole blood with LPS significantly increased protein and mRNA levels of cytokines compared to baseline (p < 0.05). However, the combination of daptomycin plus LPS did not exert any significant effect on mRNA and protein levels of IL-1β, IL-6 (high sensitivity) and TNF-α after 2 and 4 h of incubation compared to LPS incubation alone. Conclusion: Daptomycin does not affect pro-inflammatory cytokines in the early phase of endotoxemia. This is most likely due to the unique mode of action of daptomycin, its low potential to penetrate into human cells and its high affinity to bacterial cytoplasmic membranes.Keywords
This publication has 16 references indexed in Scilit:
- Immunomodulatory Effects of Fosfomycin in Experimental Human EndotoxemiaAntimicrobial Agents and Chemotherapy, 2007
- Daptomycin Susceptibility of Unusual Gram-Positive Bacteria: Comparison of Results Obtained by the Etest and the Broth Microdilution MethodAntimicrobial Agents and Chemotherapy, 2007
- Daptomycin-reversible rifampicin resistance in vancomycin-resistant Enterococcus faeciumJournal of Antimicrobial Chemotherapy, 2007
- Mechanistic and Structural Basis of Stereospecific Cβ-Hydroxylation in Calcium-Dependent Antibiotic, a Daptomycin-Type LipopeptideACS Chemical Biology, 2007
- Concentration–response relationships as a basis for choice of the optimal endpoints of the antimicrobial effect: daptomycin and vancomycin pharmacodynamics with staphylococci in an in vitro dynamic modelInternational Journal of Antimicrobial Agents, 2007
- Immunomodulatory effects of fosfomycin in an endotoxin model in human bloodJournal of Antimicrobial Chemotherapy, 2006
- Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*Critical Care Medicine, 2006
- Immunomodulatory Activities of FluoroquinolonesInfection, 2005
- Interference of Antibacterial Agents with Phagocyte Functions: Immunomodulation or "Immuno-Fairy Tales"?Clinical Microbiology Reviews, 2000
- Cytokine Measurements in Septic ShockAnnals of Internal Medicine, 1993